Americans under 50 without a college degree are dying from colorectal cancer at accelerating rates, even as the disease kills fewer older adults than at any point in recent decades. That is the central finding of a peer-reviewed study published in BMJ, which analyzed 25 years of federal death-certificate records and found that the gains from better screening and treatment have not reached everyone equally.
The research arrives at a moment of growing alarm over early-onset colorectal cancer. The American Cancer Society has reported steady increases in colorectal cancer diagnoses among younger adults for more than a decade, and the disease is now the leading cause of cancer death in American men under 50. What the BMJ study adds is an education gradient that sharpens the picture: the mortality climb is steepest among those with a high school diploma or less.
What the federal data show
Colorectal cancer remains the second-leading cause of cancer death in the United States overall, according to the National Cancer Institute’s SEER program. The BMJ researchers used the CDC WONDER database, which draws on Multiple Cause of Death files maintained by the National Center for Health Statistics, to track mortality patterns from 1999 through 2023.
Two trends moved in opposite directions. Among adults 65 and older, colorectal cancer death rates fell across the entire study period, reflecting the well-documented impact of colonoscopy screening, better surgical techniques, and targeted drug therapies. Among adults under 50, mortality shifted upward. That younger group fell largely outside routine screening guidelines for most of the study window and often received diagnoses at later, harder-to-treat stages.
When the researchers stratified by education level, recorded on death certificates, the disparity sharpened. The steepest mortality increases among younger adults clustered in people with a high school education or less. That pattern persisted after the analysis accounted for sex and race, suggesting that formal schooling serves as a marker for broader social and economic disadvantage, including the kind that shapes whether someone gets screened, how quickly symptoms are evaluated, and what treatment options are available.
Among older adults, every education group saw declining death rates, but the most educated experienced the largest drops. The implication is uncomfortable but consistent with patterns across many diseases: when new prevention tools arrive, people with more resources and health literacy benefit first, and the gap widens before it narrows.
Where the evidence has limits
Death certificates record who died and from what cause, but they cannot explain why. The study’s reliance on aggregated mortality records means it cannot separate the possible drivers of the education gap. Lower screening rates, delayed recognition of symptoms, limited access to gastroenterologists, dietary patterns, occupational exposures, and gaps in health insurance coverage could all contribute. The data do not isolate any single factor or measure how much each one matters.
A technical issue also complicates the education findings. In 2003, the U.S. standard death certificate changed how education is recorded, shifting from years of schooling to degree-based categories. The National Vital Statistics System has flagged this revision as a potential comparability problem for long-term trend analysis. Some portion of the apparent shift could reflect how education is measured rather than a real change in who is dying, particularly when comparing the earliest and most recent years in the series.
Geography is another blind spot. The CDC WONDER system provides national totals, but colorectal cancer outcomes vary widely by state and by urban or rural setting. Without detailed geographic breakdowns cross-referenced by age and education, the national trend could obscure sharply different realities in different regions. Some communities with aggressive screening outreach may be bucking the trend entirely; others may be experiencing steeper increases than the national average suggests.
The biology of early-onset colorectal cancer adds further uncertainty. Incidence has been climbing among younger adults across education levels, and researchers are investigating roles for the gut microbiome, obesity, sedentary lifestyles, and environmental exposures. The BMJ analysis cannot determine whether tumors in less-educated young adults are biologically more aggressive, whether they are simply caught later, or both. Answering that question will require studies that link tumor characteristics and treatment records to socioeconomic data, not just the education field on a death certificate.
How strong is the signal
The core data sources behind this study are among the most reliable in American public health. The CDC WONDER database and the NCHS mortality microdata files are considered the gold standard for cause-of-death analysis in the United States. The BMJ study applied standard epidemiological methods to those records and cleared peer review before publication. The central descriptive finding, that colorectal cancer mortality is rising among younger Americans while falling among older ones, carries a high degree of credibility.
The education dimension deserves a more cautious read. Death-certificate education fields are typically filled out by funeral directors or next of kin, not by the person who died. Misclassification is possible, especially for people who attended college without completing a degree. The direction of the association, lower education linked to higher mortality in younger adults, aligns with patterns documented across many chronic diseases. But the precise size of the gap carries more uncertainty than the age-based trends do.
Independent data reinforce the broader alarm. The American Cancer Society’s most recent statistics show that colorectal cancer incidence among adults under 55 has roughly doubled since the mid-1990s. The U.S. Preventive Services Task Force lowered its recommended screening start age to 45 in 2021, but surveys consistently show that awareness of that change remains uneven, particularly among adults without a college education.
What younger adults should know about screening access
For anyone under 50 who has not discussed colorectal cancer screening with a doctor, the practical message from this research is straightforward. The mortality data show that younger adults, especially those without a four-year degree, face the steepest upward trend in colorectal cancer deaths. Scheduling a conversation with a primary care provider about screening options, whether a stool-based test, a colonoscopy, or another method, is the most direct action available. That conversation is especially urgent for people with a family history of colorectal cancer or persistent symptoms such as rectal bleeding, unexplained weight loss, or sustained changes in bowel habits.
Closing the gap will take more than individual initiative. Public health campaigns that reach workers in lower-wage and hourly jobs, insurance policies that fully cover screening starting at 45, flexible clinic scheduling, and clear messaging about warning signs could all help translate decades of scientific progress into fewer deaths among the people the data show are being left behind. The mortality numbers have identified where the burden is shifting. The harder work of making sure screening and treatment reach everyone has yet to catch up.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
